Abstract
Biosimilars have introduced new opportunities to reduce the disproportionately high US healthcare spending on biologic medications. This article describes strategic utilization management program i... Plain language summary Biologics are medications that are effective treatments for many patients but have a high price that affects patients and healthcare systems. Biosimilars are medications that...
Funding Information
  • Coherus Biosciences

This publication has 4 references indexed in Scilit: